The Truth Is Out There

Posts tagged ‘health’

Universe 25 Explains The Great Society’s Catastrophic Failure And This Country Had Better Listen Up And Listen Up Quickly!


Universe 25 was not a fable about rodents; it was a behavioral model of what happens when structure, hierarchy, and purpose are replaced by unlimited external provisioning. Dr. John Calhoun observed that when mice lived in a habitat where every material need was met automatically, their social roles collapsed. Male withdrawal, weakened parental investment, falling fertility, and eventually a complete demographic crash followed. It is tempting to think humans would behave differently, but the striking parallels to what happened under LBJ’s Great Society suggest otherwise. This claim seems bold at first glance. Yet careful reflection shows it to be tragically plausible.

John B. Calhoun was an American ethologist and behavioral researcher who is most famous for his “Universe 25” experiment. Conducted between 1968-1973.

To understand the parallel, we must first remind ourselves what Calhoun found. Universe 25 provided abundance without effort. Food appeared without foraging. Shelter required no construction. Predators were removed. At first, the population expanded rapidly. Then something surprising occurred. As resources remained stable, the social structure atrophied. Dominant males withdrew or fixated on repetitive, self-soothing behavior. Females stopped caring for offspring. Infanticide increased. Fertility collapsed. Eventually, the final generation, the so-called “Beautiful Ones,” ceased to reproduce, withdrew from contact, and spent their days grooming or eating in isolation. Abundance without purpose created behavioral degradation so deep that the population could not recover even when conditions remained materially perfect.

If this seems remote from human affairs, consider what Black Americans had achieved before Washington intervened. Despite the severe constraints imposed by segregation, Black families were intact and resilient. More than 85% of Black children were born to married parents in the early 1960s, an astonishing rate for any urban poor population. Poverty existed, but social cohesion was strong. Churches, fraternal organizations, and family networks created structure and responsibility. There was purpose, and there were roles. These institutions helped people navigate unjust external conditions and provided the scaffolding for upward mobility.

Then the Great Society arrived. Washington attempted to replace family, church, and community with federal programs. The intent was compassionate. Yet intent does not override human nature. Welfare incentives rewarded the absence of fathers. Public assistance replaced the reciprocal obligations that had sustained families. The cultural norm that linked marriage, sex, and child rearing was severed. The numbers show how quickly the damage spread. Prior to 1965 fewer than 2% of black women received any form of public assistance. By 1970 roughly 36% did. An eighteen-fold increase in five years reveals not gradual social evolution but a policy driven shock.

Fertility followed a similar arc. In 1965 the General Fertility Rate for black women ages 15 to 44 stood at 140.3 births per 1,000 women. By 1970 it had fallen to 123.5. Today it has collapsed to 45.8. A two thirds decline in sixty years is not an ordinary demographic adjustment. It is the signature of a community losing its social structure. Calhoun observed that once parental roles erode, fertility does not rebound simply because material conditions are comfortable. The behavioral patterns produced by disrupted roles persist across generations. In short, once the social fabric tears, later generations cannot easily repair it.

The expansion of SNAP reinforced the pattern. Food stamps did not reach every county until 1974. Yet by 1980 roughly 35% of black households used them. Today that figure is 52%. More than half of black households now rely on a federal provisioning system to meet basic nutritional needs. Calhoun found that abundant food provided without effort weakened social behaviors related to care, discipline, and responsibility. We see a disturbing parallel. Federal provisioning was meant to provide relief. Instead, it displaced the social norms that sustain families.

The collapse of marriage tells the same story. In 1965 over 85% of black children were born to married parents. By 1970 fewer than 63% were. By 1980 that figure had fallen below 50%. Today it sits below 30%. No developed society has ever seen such a fast decline in marriage without accompanying social dysfunction. When marriage collapses, so does the structure that teaches children discipline, reciprocity, and responsibility. Calhoun would not have been surprised by these outcomes. When a system replaces organic roles with external provisioning, social roles dissolve.

Some readers may resist this interpretation. Perhaps they believe social structures collapsed because of lingering discrimination or economic shocks. These factors matter, but they cannot explain the timing. The most dramatic changes occurred precisely when Great Society programs expanded. Nor can they explain why black families remained stable during far harsher periods before the 1960s. When we look at the causal chain, the policies come first, followed by the collapse in marriage, the surge in welfare use, the decline in fertility, and the rise of multi-generational dependency.

Consider Calhoun’s central insight. A system that removes incentives for productive behavior while failing to reinforce social norms does not create flourishing. It creates a behavioral sink. In Universe 25 the sink emerged not because conditions were harsh but because they were artificially easy. The mice did not need each other, so they stopped forming healthy bonds. They did not need to protect or nurture, so parental roles decayed. They did not need to cooperate, so hierarchy collapsed. What remained was isolation, withdrawal, and the slow erosion of purpose.

Translate this into human social terms. When the state displaces fathers, fathers withdraw. When bureaucracies replace parental responsibility with monthly checks, parental investment declines. When food appears without effort, the link between work and provision breaks. When norms collapse, marriage becomes optional, then rare. The social ecosystem enters a downward spiral. This is precisely what happened in many black communities after the 1960s. The Great Society redistributed material goods while undermining the structures that gave life meaning.

Why does this matter today? Because Democrats still treat the Great Society as an untouchable legacy. They defend it with quasi-religious devotion. Their attachment persists even as the data show catastrophic outcomes. If the goal was to alleviate poverty, they failed. If the goal was to strengthen families, they failed. If the goal was to promote flourishing, they failed. And yet they demand more of the same policies. Calhoun would call this expansion of provisioning a deepening of the behavioral sink.

A reasonable reader might now ask how we should respond. We begin by recovering the insight that material assistance without social norms destroys the very communities it claims to help. Next, we must restore the institutions that originally sustained black families. Churches, civic groups, and strong families cannot be replaced by bureaucracies. Finally, we must ask why a political movement insists on maintaining policies that corrode family life. How do we save America if our policies are designed to destroy the structures that make America possible?

The lesson of Universe 25 is sobering. When abundance is provided without structure, communities decline. The Great Society followed the same script. Calhoun’s experiment warned us. We ignored it. We still have time to reverse course, but doing so requires the courage to admit that our social experiment failed and that the path to renewal runs through responsibility, not dependency.

mRNA Jabs: The Deadly Gift That Keeps On Giving


No one who understands the politics of ‘the science’ trusts it or will allow a gene therapy bioweapon into their bodies or of those they love and care for. Why are these shots still available?

Aussie17 writes a great blog. Below is posted Part 1 of his [?]/her [?] vitally important and compelling 2-part series linking the COVID jabs, through clean, reliable data from Singapore, with the one and only medication for a previously rare, devastating, invariably fatal disease called Amyotrophic Lateral Sclerosis (ALS).

There is only one use for the particular drug followed in the stack: ALS. Since the people taking it are ALS patients who have a short lifespan, if more is sold because more people are taking it. That can only be because more people have ALS.
Q: Why do more people have ALS, decreased fertility, auto immune diseases, turbo cancer and excess death?
A: ABTS [Anything but the shots]

It is urged that you read these two pieces and do several things: first, commit to being the voice of truth about these indescribably dangerous weapons against humanity disguised as “vaccines”. They are not. And clean statistics from around the world make that horrifyingly clear. Only governments and their lackies can find any way to deny this. It is up to us, all of us, to amplify this message.

Second, commit to doing whatever is necessary to protect your own body and that of people you have control over (parents for minor children, for example).

That means never, ever [again?] permit this or any other “untested” government-provided miracle snake oil substance into your body (or theirs).

Vintage Salesman GIF by Challenger

Third, in order to educate yourself, and check out the idea that every aspect of our lives is already permeated by the United Nations parasite, perform this quick experiment: using the search engine of your choice, enter the following (filling in the blank with your town or agency impacting your profession or State or Province or country):
” List, with references and links, all of the UN-derived, UN-compliant, UN-related or UN-adjacent programs, policies, protocols, policies and partnerships which impact directly or indirectly [fill in the blank].”

It is promised that that your jaw will be somewhere in the vicinity of your knees when you see what comes back.

Now here is Part 1 of Aussie17’s important correlation of deeply meaningful information:

PharmaFiles by Aussie17

The Jab That Keeps on Giving…300% Increase in ALS(Motor Neuron Disease) Drug sales reveals Singapore’s Hidden Health Horror Story!

A big part of Big Pharma is spinning a good story around sales numbers for the bosses. Nail the narrative, and you’re golden for another year. Botch it, and you’re packing your desk.

Why is this important? Well, for quite a few reasons, but a big one is because, especially in light of Dr. Prasad’s letter acknowledging that Covid jabs kill kids, with the mRNA shots still on the market and new mRNA jabs, including the uber-deadly replicon shots, being approved all the time, especially for kids (and, thanks to Merck, for your pets, too), we are dealing with weak-kneed damage control, not the beneficent or beneficial regulatory service to the public. We pay for regulation, not rubber-stamped death and disease but that is what we get.

Doin’ the Ol’ “HHS is Here for You, Regulating to Protect Your Health, Bobby Kennedy’s Our Guy” Rag

Let it be clear: Bobby knows full well that mRNA jabs are bioweapons. Prasad knows. Bhattacharya knows. There is, and has never been, a dearth of knowledge of how deadly these shots are. Pfizer and Moderna know. So does the Department of Defense.
Anyone who genuinely cares about ending the REAL pandemic, not the COVID propagandemic nonsense, but the deadly reality of the medical murders and the public health harms and, most of all, the bioweapon jabs, would not play nice, bide his time and be a good politician. He would move heaven and earth to end the deadly scourge of gene editing, death dealing weapons killing and maiming us while they destroy our ability to reproduce humankind.

Or he could pretend to be working on it and not accomplish anything even coming close to protecting the public from the bioweapon.

Hey, Mr. Secretary (and Mr. President), did you get caught with your regulatory pants down? Well, just keep on doing what you have done for nearly a year: pretend you are doing performance art and you really meant to be in that awkward position and indicate how much thought went into getting your rear end exposed.

That’s the science we are supposed to trust, after all. And we had that revelation about autism to trust, too. Now that was some seriously trustworthy science, right?

Then, because the public let you get away with that, you can just keep on doing more of same, right?

But don’t, for God’s sake, waste all the time and money and creativity that has gone into this decades long, untold trillions of dollars’ worth of bioweapon program by interfering with it! No, Siree Bob! Cover your tracks first, lie out of every orifice you and your associates can make any sounds out and keep the bioweapons in the rapid approval pipeline.

Most important of all, of course, cover your own ass if you can manage it, and keep on doing what you’re doing.

Maybe nobody will notice while they are exterminated from the bioweapons on the shelves and in the clinics.

Or maybe we will. And maybe we will eject the deadly UN parasite from every cell in the Body Politic and make some real headway to recovery

Nothing less.

And neither the head of the Executive Branch of the US government nor his appointee over at Health and Human Services has done so. Meanwhile, we suffer and die through an entirely man-made plague.

As it turns out, hiding it in Singapore is quite difficult. Thus, this outstanding two-part revelation.

Who is behind it? The genocidal maniacs who think you and I are disposable at their whim and pleasure. That’s right: the globalist parasites who operate the United Nations for their pleasure and profit, and for our pain and punishment. We, after all, are the carbon they intend to eliminate.

The solution? a good, comprehensive detox to get the UN and its bits and pieces out of our lives, our bodies, our government, our schools, our town halls, our clinics and hospitals, our airports, our banks and everywhere else.

Learn more, a lot more, at PreventGenocide2030.org.

WHO–Gates Blueprint for Global Digital ID, AI-Driven Surveillance, and Life-Long Vaccine Tracking for Every Person


Automated, cradle-to-grave traceability for “identifying and targeting the unreached.”

In a document published in the October Bulletin of the World Health Organization and funded by the Gates Foundation, the World Health Organization (WHO) is proposing a globally interoperable digital-identity infrastructure that permanently tracks every individual’s vaccination status from birth.

The dystopian proposal raises far more than privacy and autonomy concerns: it establishes the architecture for government overreach, cross-domain profiling, AI-driven behavioral targeting, conditional access to services, and a globally interoperable surveillance grid tracking individuals from birth.

It also creates unprecedented risks in data security, accountability, and mission creep, enabling a digital control system that reaches into every sector of life.

The proposed system:

  • integrates personally identifiable information with socioeconomic data such as “household income, ethnicity and religion,”
  • deploys artificial intelligence for “identifying and targeting the unreached” and “combating misinformation,”
  • and enables governments to use vaccination records as prerequisites for education, travel, and other services.

What the WHO Document Admits, in Their Own Words

To establish the framework, the authors define the program as nothing less than a restructuring of how governments govern:

“Digital transformation is the intentional, systematic implementation of integrated digital applications that change how governments plan, execute, measure and monitor programmes.”

They openly state the purpose:

“This transformation can accelerate progress towards the Immunization agenda 2030, which aims to ensure that everyone, everywhere, at every age, fully benefits from vaccines.”

This is the context for every policy recommendation that follows: a global vaccination compliance system, digitally enforced.

1. Birth-Registered Digital Identity & Life-Long Tracking

The document describes a system in which a newborn is automatically added to a national digital vaccine-tracking registry the moment their birth is recorded.

“When birth notification triggers the set-up of a personal digital immunization record, health workers know who to vaccinate before the child’s first contact with services.”

They specify that this digital identity contains personal identifiers:

“A newborn whose electronic immunization record is populated with personally identifiable information benefits because health workers can retrieve their records through unique identifiers or demographic details, generate lists of unvaccinated children and remind parents to bring them for vaccination.”

This is automated, cradle-to-grave traceability.

The system also enables surveillance across all locations:

“[W]ith a national electronic immunization record, a child can be followed up anywhere within the country and referred electronically from one health facility to another.”

This is mobility tracking tied to medical compliance.

2. Linking Vaccine Records to Income, Ethnicity, Religion, & Social Programs

The document explicitly endorses merging vaccine status with socioeconomic data.

“Registers that record household asset data for social protection programmes enable monitoring of vaccination coverage by socioeconomic status such as household income, ethnicity and religion.”

This is demographic stratification attached to a compliance database.

3. Conditioning Access to Schooling, Travel, & Services on Digital Vaccine Proof

The WHO acknowledges and encourages systems that require vaccine passes for core civil functions:

“Some countries require proof of vaccination for children to access daycare and education, and evidence of other vaccinations is often required for international travel.”

They then underline why digital formats are preferred:

“Digital records and certificates are traceable and shareable.”

Digital traceability means enforceability.

4. Using Digital Systems to Prevent ‘Wasting Vaccine on Already Immune Children’

The authors describe a key rationale:

“Children’s vaccination status is not checked during campaigns, a practice that wastes vaccine on already immune children and exposes them to the risk of adverse events.”

Their solution is automated verification to maximize vaccination throughput.

The digital system is positioned as both a logistical enhancer and a compliance enforcer:

“National electronic immunization records could transform how measles campaigns and supplementary immunization activities are conducted by enabling on-site confirmation of vaccination status.”

5. AI Systems to Target Individuals, Identify ‘Unreached,’ & Combat ‘Misinformation’

The WHO document openly promotes artificial intelligence to shape public behavior:

“AI… demonstrate[s] its utility in identifying and targeting the unreached, identifying critical service bottlenecks, combating misinformation and optimizing task management.”

They explain additional planned uses:

“Additional strategic applications include analysing population-level data, predicting service needs and spread of disease, identifying barriers to immunization, and enhancing nutrition and health status assessments via mobile technology.”

This is predictive analytics paired with influence operations.

6. Global Interoperability Standards for International Data Exchange

The authors call for a unified international data standard:

“Recognize fast healthcare interoperability resources… as the global standard for exchange of health data.”

Translated: vaccine-linked personal identity data must be globally shareable.

They describe the need for “digital public infrastructure”:

“Digital public infrastructure is a foundation and catalyst for the digital transformation of primary health care.”

This is the architecture of a global vaccination-compliance network.

7. Surveillance Expansion Into Everyday Interactions

The WHO outlines a surveillance model that activates whenever a child interacts with any health or community service:

“CHWs who identify children during home visits and other community activities can refer them for vaccination through an electronic immunization registry or electronic child health record.”

This means non-clinical community actors participating in vaccination-compliance identification.

The authors also describe cross-service integration:

“Under-vaccinated children can be reached when CHWs and facility-based providers providing other services collaborate and communicate around individual children in the same electronic child health records.”

Every point of contact becomes a checkpoint.

8. Behavior-Shaping Through Alerts, Reminders, and Social Monitoring

The WHO endorses using digital messaging to overcome “intention–action gaps”:

“Direct communication with parents in the form of alerts, reminders and information helps overcome the intention–action gap.”

They also prescribe digital surveillance of public sentiment:

“Active detection and response to misinformation in social media build trust and demand.”

This is official justification for monitoring and countering speech.

9. Acknowledgment of Global Donor Control—Including Gates Foundation

At the very end of the article, the financial architect is stated plainly:

“This work was supported by the Gates Foundation [INV-016137].”

This confirms the alignment with Gates-backed global ID and vaccine-registry initiatives operating through Gavi, the World Bank, UNICEF, and WHO.

Bottom Line

In the WHO’s own words:

“Digital transformation is a unique opportunity to address many longstanding challenges in immunization… now is the time for bold, new approaches.”

And:

“Stakeholders… should embrace digital transformation as an enabler for achieving the ambitious Immunization agenda 2030 goals.”

This is a comprehensive proposal for a global digital-identity system, permanently linked to vaccine status, integrated with demographic and socioeconomic data, enforced through AI-driven surveillance, and designed for international interoperability.

It is not speculative, but written in plain language, funded by the Gates Foundation, and published in the World Health Organization’s own journal.

CDC, Pfizer Create Cleavage Cite-Optimized Bird Flu Constructs for New mRNA Jab: ‘npj Vaccines’


Using “the same platform methods used for Pfizer’s COVID-19 and seasonal influenza mRNA vaccines.”

Researchers from the U.S. Centers for Disease Control and Prevention (CDC) and Pfizer Inc. have created new, engineered H5 bird flu influenza genetic constructs, including a codon-optimized hemagglutinin (HA) gene with a synthetically altered cleavage site, as documented in a Saturday npj Vaccines publication.

According to the authors, the stated purpose of the study was to evaluate an mRNA-based H5 vaccine, which they describe as “a nucleoside-modified mRNA construct encoding the full-length, codon-optimized HA protein with the polybasic cleavage site deleted from A/Astrakhan/3212/2020 A(H5N8).”

The paper confirms that the engineered HA used in the study was genetically modified beyond its purported natural form.


Cleavage Site Optimized

The authors state that the cleavage site was synthetically altered, writing that the polybasic amino acids were “mutated from ‘REKRRKR’ to ‘RETR’.”

The cleavage site is like a switch that must be cut to turn the flu pathogen “on” so it can infect cells, and if this site can be cut by many types of enzymes in the body, the virus can spread more and cause worse disease.

LNPs for mRNA Therapeutics

The engineered constructs were then formulated into lipid nanoparticles following “the same platform methods used for Pfizer’s COVID-19 and seasonal influenza mRNA vaccines.”

The work was conducted by multiple CDC branches, including the Influenza Division, the Division of High-Consequence Pathogens and Pathology, and the Office of Advanced Molecular Detection.

Pfizer Scientists at BSL-3 Lab

It was carried out by Pfizer scientists at the company’s Pearl River, NY facility, with additional involvement from ORISE.

The authors specify that “all research involving HPAI A(H5N1) viruses was conducted within Biosafety Level 3 enhanced (BSL-3E) or ABSL-3 facilities at the CDC.”

100% Transmission Rate

To test the performance of the engineered constructs, the CDC–Pfizer team conducted live-virus challenge experiments using human-derived H5N1 isolates.

The ferrets were infected with virus formations “A/Chile/25945/2023” and “A/Michigan/90/2024… from a farm worker exposed to infected cattle.”

Using these human isolates, the researchers documented efficient mammal-to-mammal spread, reporting a “100% transmission rate” in unvaccinated ferrets.

Funding & Conflicts of Interest

The funding disclosures indicate direct federal and corporate sponsorship.

The authors state: “This work was funded by the US Centers for Disease Control and Prevention and by Pfizer Inc.”

The authors also disclose full corporate participation in the scientific process, writing: “Pfizer was involved in the design, analysis, and interpretation of the data in these research studies, the writing of this report, and the decision to publish.”

Additionally, the paper notes that Pfizer researchers associated with the project are “inventors on patent applications relating to influenza mRNA compositions.”

Bottom Line

The new study documents that CDC and Pfizer jointly engineered new H5 constructs through codon optimization and cleavage-site mutation, formulated them using Pfizer’s mRNA-LNP platform, and then tested them against recent human H5N1 isolates inside CDC BSL-3E laboratories.

The result is a federally backed, corporate-driven program in which U.S. authorities and Pfizer quietly engineered H5 influenza genetics and tested them with human-infecting H5N1—blurring the line between vaccine development and high-risk pathogen manipulation.

The dangerous experiments raise national security concerns.

NIAID Funds Creation of Chimeric H5N1 Bird Flu Viruses With Modified Cleavage Sites and Enhanced Mammalian-Cell Expression: ‘npj Vaccines’


Amid worries of a coming avian influenza pandemic.

A new study preprint published last week in the journal npj Vaccines describes a multinational research program that designed, engineered, and tested synthetic versions of the H5N1 bird flu virus’s hemagglutinin protein—one of the key components that allows the virus to infect cells.

The scientists altered these genetic sequences, delivered them into animals using advanced DNA and lipid-nanoparticle (LNP) technologies, and then conducted lethal challenge experiments with highly pathogenic H5N1 viruses inside a Canadian government biocontainment facility.

This means researchers created synthetic versions of a dangerous flu component, injected them into mice using vaccine-style technologies, and then exposed the animals to very deadly strains of H5N1 to test how well the constructs worked.

The study is authored by a large team from the United States, Canada, and Europe, including researchers from the Wistar Institute, the University of Pennsylvania, the Public Health Agency of Canada, and the University of Bologna.


Funding Sources

The research was funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID) through its Collaborative Influenza Vaccine Innovation Centers (CIVIC) program under contract 75N93019C00051.

This is a federal vaccine-development initiative said to be designed to prepare the U.S. for future influenza outbreaks using rapidly adaptable genetic platforms.

But the creation of new viruses raises national security concerns.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

Additional support came from the W.W. Smith Charitable Trust Distinguished Professorship in Cancer Research and The Jill and Mark Fishman Foundation.

In other words, the work was paid for by the same federal agencies responsible for pandemic vaccine programs, along with private biomedical foundations.

Institutions Involved

The experiments were carried out by a coordinated network of laboratories:

  • The Wistar Institute (Philadelphia) designed and built the synthetic H5N1 DNA constructs, performed immune studies, and conducted structural modeling using AlphaFold 3.
  • The University of Pennsylvania assisted with lipid-nanoparticle formulation and microbiology methods.
  • The Public Health Agency of Canada’s National Microbiology Laboratory in Winnipeg performed the live H5N1 infections and lethal challenge experiments, including tests using a recombinant H5N1 virus constructed from synthetic gene segments.
  • The University of Bologna contributed additional biotechnology expertise.

The U.S. labs designed and built the engineered genetic materials, and the Canadian government lab carried out the dangerous live-virus testing.

The authors include: Ebony N. Gary, Nicholas J. Tursi, Casey E. Hojecki, Robert Vendramelli, Martina Tomirotti, Bryce Warner, Cory Livingston, Thang Truong, Yangcheng Gao, Sachchidanand Tiwari, Norbert Pardi, Darwyn Kobasa, and senior author David B. Weiner.

What Is Scientifically Alarming

Several aspects of this research stand out as high-risk from a biodefense perspective, even though the work is framed as vaccine development.

1. Synthetic Genetic Engineering of H5N1 Components

The team did not merely study existing viruses.

They engineered new synthetic versions of the H5N1 hemagglutinin gene, including codon optimization (which boosts expression in human cells) and deliberate modification of the protease cleavage site, a region strongly linked to H5N1’s virulence.

They edited the part of the virus that helps determine how dangerous it is.

2. Construction of a Recombinant H5N1 Virus From Synthesized Gene Segments

The researchers created a chimeric H5N1 virus by combining gene segments that were commercially synthesized and assembled from cloned DNA.

They then rescued this artificial virus using reverse-genetics techniques.

This means they built a new lab-made version of H5N1, piece-by-piece, using artificial DNA.

3. Use of LNP Delivery and Electroporation to Express Viral Genes Inside Animals

The study delivered the synthetic HA genes using LNPs (the same technology used in COVID-19 mRNA vaccines) and electroporation, a technique that uses electrical pulses to force genetic material into cells.

Both approaches greatly increase how efficiently engineered genetic material can spread through tissues.

These tools make it much easier for lab-designed genetic material to take hold inside the body.

4. Lethal Challenge Work Using High-Dose H5N1

Mice were exposed to 10 times the lethal dose (10 LD50) of highly pathogenic H5N1 strains—including both natural isolates and the lab-built recombinant virus.

They infected animals with very large amounts of a deadly virus to test whether the synthetic constructs gave protection.

5. Corporate Ties of the Senior Author

The senior scientist, David B. Weiner, discloses paid relationships with Pfizer, AstraZeneca, Sanofi, Inovio, Flagship, and others.

This means the research directly intersects with large pharmaceutical companies that develop genetic vaccines and related technologies, raising conflicts of interest worries.

Why This Matters for Policymakers

This study demonstrates that federal funding is supporting research with clear dual-use potential, meaning it could advance vaccines or, if misapplied, enable the construction or enhancement of dangerous influenza viruses.

The same techniques used to create synthetic vaccine antigens—codon optimization, cleavage-site modification, LNP delivery, and recombinant virus assembly—can also be used to create novel viral strains with properties that do not currently exist in nature.

The technical sophistication is notable, especially the deliberate editing of cleavage sites and the full reconstruction of an H5N1 virus from cloned fragments, which is uncommon outside of specialized influenza-engineering programs.

This work shows that laboratories funded by the U.S. government and partnered with foreign agencies are actively engineering pieces of dangerous bird flu viruses and testing them in high-security facilities.

The stated goal is to develop better vaccines, but the methods overlap with techniques traditionally associated with gain-of-function research, which can create new biological risks if not tightly controlled.

USDA–NIH–University of Georgia–Mount Sinai Team Aerosolizes Lab-Engineered ‘Chimeric’ Influenza Frankenviruses: Journal ‘npj Vaccines’


Raising national security concerns.

A Thursday npj Vaccines study confirms U.S. federal agencies, including the U.S. Department of Agriculture (USDA) and the National Institutes of Health (NIH), funded the laboratory creation of genetically engineered two influenza viruses (H9N2/H5N2) built from plasmids, artificial gene fusions, synthetic insertions, and modified genome segments.

The work was carried out by researchers at the University of Georgia, the Icahn School of Medicine at Mount Sinai, and the U.S. National Poultry Research Center, Agricultural Research Service, USDA.

The authors listed on the study are: “Flavio Cargnin Faccin, L. Claire Gay, Dikshya Regmi, Robert Hoelzl, Teresa D. Mejías, Darrell Kapczynski, Florian Krammer & Daniel R. Perez.”

The study’s funding confirms direct federal involvement.

“Funding for this work includes grants… National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture (USDA) Grant award numbers 2021-67015-33406 and 2024-67015-42736, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) Contract number 75N93021C00014.”


Construction of the Engineered Viruses

The researchers did not isolate a purported virus from nature.

They built new viruses entirely through reverse genetics, using plasmid DNA transfected into human and dog cell lines.

The paper states: “Recombinant viruses were rescued by reverse genetics using the 8-plasmid system and helper plasmids in a coculture of HEK293T and MDCK cells.”

The process is described explicitly.

According to the authors, “1 µg of each plasmid was mixed… and used to overlay the cell coculture.”

Viral stocks were then expanded artificially rather than occurring naturally, as the study reports: “Viral stocks were generated in 10-day-old specific pathogen-free (SPF) eggs.”

These details confirm that the viruses were constructed in the laboratory, rescued from DNA, and amplified in eggs.

‘Chimeric’ Pathogens

The viruses created under USDA and NIH funding are laboratory-assembled chimeras—genomes stitched together from engineered parts that do not exist in nature.

The study shows that two influenza proteins were fused into a single artificial gene, something no wild virus carries.

As the authors write: “Segment 2 was modified to encode a chimeric PB1-M2 open reading frame (ORF) separated by a glycine-glycine-glycine-glycine-serine (G4S) spacer.”

This forces the virus to make an unnatural hybrid protein.

To ensure the virus depends on this man-made fusion protein, its normal version of M2 was deliberately shut off.

The paper states: “Segment 7 was modified by introducing multiple early stop codons in the M2 ORF via site-directed mutagenesis to prevent its expression.”

This eliminates the native M2 and locks the virus into the engineered design.

The researchers also inserted a synthetic 58–amino acid sequence into the HA segment, including an artificial peptide not found in any influenza strain.

The methods describe this as: “Segment 4… was modified to insert a 58-amino-acid-long sequence… which included the unique 8-amino-acid peptide… ‘DRPAVIAN.’”

Another modification swaps out the cleavage site of an H5 virus and replaces it with one taken from a human 1934 H1N1 strain, altering how the virus activates inside host cells.

The authors state: “The H5 HA HPAI cleavage site was replaced with that of the A/Puerto Rico/8/1934 (H1N1) (PR8) strain.”

Finally, the virus was engineered to manufacture a chicken immune-signaling molecule from inside infected cells.

The study confirms: “The mature protein-coding sequence of chicken IL-18… was subcloned in frame with the NA ORF.”

These combined changes—fusion genes, disabled native proteins, synthetic inserts, human-strain cleavage sites, and cytokine-expression modules—create a virus with properties that no purported natural influenza lineage carries.

Aerosol Exposure in Animals

The researchers then exposed day-old chickens to the engineered viruses through aerosolized live-virus delivery.

The methods describe this process clearly, all done within BSL-3 lab conditions:

“One-day old SPF White Leghorn chickens… were vaccinated via aerosol using an aerosol chamber… A 5 mL volume of MLV-H9N2-IL was loaded into the Aeroneb lab nebulizer, resulting in an average exposure of 1×10⁶ EID50/chicken… The exposure lasted for 15 min.”

This confirms that the USDA- and NIH-funded engineered viruses were not only constructed but also introduced into animals through airborne delivery.

Bottom Line

The study documents how U.S. federal agencies oversaw the full laboratory assembly of engineered influenza viruses—built from plasmids, redesigned through reverse genetics, and altered with fusion genes, stop-codon knockouts, synthetic peptide insertions, cytokine-expression modules, and foreign cleavage sites.

These are not environmental isolates; they are fully man-made constructs created inside U.S. government and university laboratories under USDA and NIH funding.

The viruses were then delivered to live animals by aerosol, demonstrating not only construction capability but functional deployment.

Work of this nature carries obvious national-security implications: it establishes the technical capacity to design, modify, and disseminate engineered influenza strains whose properties cannot be predicted from any purported natural lineage.

FDA Chief Says Lyme Disease Came from U.S. Military Lab 257, Suggests HIV Came from African Lab (Video)


“It came from Lab 257 on Plum Island.”

In a stunning exchange on the PBD Podcast (Episode 690), U.S. Commissioner of Food and Drugs (FDA) Dr. Marty Makary, a Johns Hopkins surgeon, dropped two bombshell admissions about pathogen origins—one about HIV, the other about Lyme disease.

Dr. Makary openly entertained the possibility that HIV “may very well have come from a lab in Africa,” saying the film Thank You, Dr. Fauci “explore[s] a non-traditional narrative, which has not gotten the attention it deserves.”

HIV (Human Immunodeficiency Virus) is said to be a retrovirus that targets and destroys CD4 T cells in the immune system, weakening the body’s ability to fight infections and potentially leading to AIDS if untreated.

When asked where Lyme disease originated, Makary answered directly: “I can tell you with a high degree of probability. It came from Lab 257 on Plum Island.”

Lyme disease is a bacterial infection caused by Borrelia burgdorferi, transmitted through bites from infected blacklegged ticks, often marked by an expanding “bull’s-eye” rash, fever, fatigue, and joint pain.

The head of the FDA has admitted that two major diseases originated not in nature, but in government laboratories, raising questions about other disease origins.


HIV: ‘It May Very Well Have Come from a Lab in Africa’

Makary described how mainstream institutions avoid uncomfortable evidence about HIV’s beginnings.

When pressed on the origin of AIDS, he said the following:

“They explore a non-traditional narrative, which has not gotten the attention it deserves. And that is that it may very well have come from a lab in Africa.”

Makary is one of the most publicly visible medical figures in the United States—Hopkins professor, long-time NIH-funded surgeon, and prominent FDA advisor.

His admission directly contradicts decades of official insistence that HIV was unquestionably a zoonotic spillover.

Lyme Disease: ‘It came from Lab 257 on Plum Island’

When the conversation turned to Lyme disease—which afflicts millions of Americans—Makary said:

“I can tell you with a high degree of probability. It came from Lab 257 on Plum Island just outside of Connecticut, 25 miles from Lyme, Connecticut, where the first case was described.”

He then explained how he knows:

“First of all, you can read the book Bitten. It’s a great book.”

And he explained who the U.S. brought to Plum Island after WWII:

“When the Nazi war criminal doctors were executed in Nuremberg, at least one of them was spared and brought to the United States so that his mind could be used by the US military for so-called Biodefense. And they put him on Plum Island and he had said very openly that he believed an incredible form of biowarfare was infecting ticks. And that that’s what Lyme disease is.”

Makary is referring to the notorious Erich Traub, the Nazi bioweapons scientist recruited by U.S. military intelligence.

“A bunch of mad scientists doing things… How many physicians know that it came from Lab 257? Approximately 1%.”

He ended with the warning that the public health establishment refuses to confront:

“Just because you can do something doesn’t mean you should do it. And sometimes we can cause more harm than we can good by messing with Mother Nature.”

Once the FDA commissioner concedes that two major diseases came from government labs, the narrative of “natural outbreaks” collapses on its own.

The only thing left to find out is how far these patterns go.

WHO Deploys National Pandemic Influenza Surveillance Grid in Egypt—270 Officers Trained for Real-Time Monitoring Across 30 Sentinel Sites


As countries engineer avian influenza bird flu pathogens without restraint.

The World Health Organization and Egypt’s Ministry of Health just completed a national-scale workshop training nearly 300 surveillance officers to expand real-time monitoring of influenza and other respiratory pathogens across the country.

The move comes as this website has been tracking multiple governments performing gain-of-function experiments on avian influenza “bird flu” pathogens (see below this article), raising worries of another orchestrated, man-made pandemic.

The WHO announcement frames the workshop as routine and annual, masking the scale of the expansion and the integration of surveillance functions under WHO guidance.

“The annual meeting and accompanying workshop on integrated surveillance of acute respiratory infections (ARIs), conducted by the Egyptian Ministry of Health and Population in collaboration with the World Health Organization (WHO) Country Office in Egypt, brought together around 270 public health professionals.”

More than a simple “meeting,” this represents a consolidation of a national respiratory surveillance grid.

Two hundred and seventy surveillance officers trained at once sounds more like a deployment than a workshop.

The framing as “annual” makes the expansion appear normal and non-threatening when, in reality, it marks a significant expansion of WHO’s operational footprint inside Egypt’s health system.


Thirty Sentinel Sites Feeding a Unified National Surveillance Grid

The announcement identifies the personnel being trained, revealing a full-spectrum surveillance workforce (epidemiology, clinical staff, data specialists) rather than a narrow set of influenza experts.

“The participants, all involved in surveillance, included epidemiologists, data officers, physicians, nurses and laboratory specialists drawn from 30 ARI sentinel sites across 15 governorates.”

This proves the surveillance integration is nationwide.

“Sentinel sites across 15 governorates” means Egypt’s surveillance network is now being unified under a single reporting system.

Bringing in data officers signals the transition to real-time digital surveillance and automated reporting pipelines that feed directly into WHO’s global systems.

A Surveillance Framework That Never Powers Down

The WHO announcement reveals the core mission: strengthen surveillance for influenza and all respiratory viruses—not limited to outbreaks or emergencies.

“The sessions aimed to strengthen national capacities in disease surveillance for influenza and other respiratory viruses and improve preparedness for respiratory disease threats, particularly those with pandemic potential.”

They want to treat all respiratory viruses—seasonal or otherwise—as potential triggers for global coordination.

The phrase “other respiratory viruses” quietly expands surveillance beyond influenza to include COVID, avian flu, MERS, and any future pathogen, making continuous monitoring the norm.

This is how perpetual surveillance infrastructures are justified.

The workshop covers multiple pathogen classes, including zoonotic viruses, merging animal-origin threats with routine respiratory surveillance.

“The discussions covered a wide range of topics, including updates on the global and national epidemiological situation of influenza, COVID-19, avian influenza, Middle East respiratory syndrome coronavirus (MERS-CoV) and zoonotic respiratory infections.”

So the system is designed to take in constant “signal noise” from zoonotic sources—livestock, poultry, wildlife.

Zoonotic data is always active, which means alert conditions can always be justified.

Folding zoonotic viruses into human surveillance pipelines is a central feature because it guarantees a steady stream of “pandemic potential” warnings.

WHO Uses ‘Performance Evaluations’ to Enforce Surveillance Compliance

The announcement describes the unification and standardization of national operating procedures, indicating that Egypt’s surveillance mechanics are being aligned directly with WHO standards.

“Participants reviewed standard operating procedures for ARI and influenza-like illness (ILI) sentinel surveillance and laboratory operations, alongside findings from performance evaluations.”

The mention of “performance evaluations” means WHO is grading Egypt’s compliance with global surveillance standards.

The evaluations will serve as a mechanism for harmonizing Egypt’s protocols with WHO’s prescribed methods.

This is an oversight structure.

Once surveillance is standardized, WHO essentially co-authors the national surveillance workflow.

Building the Digital Backbone of a Permanent Respiratory Surveillance State

The WHO press release goes on to introduce the digital component—data integration, dashboards, and real-time reporting—showing that Egypt’s network is being plugged into a centralized digital surveillance architecture.

“They explored how digital tools and platforms can enhance ARI data quality and timeliness and discussed data reporting through the National Electronic Disease Surveillance System (NEDSS) and the ARI/ILI Power BI dashboard which are used to collect, analyse and visualize respiratory surveillance disease data.”

The system they’re describing allows centralized ingestion of respiratory data across Egypt, instant analytics, automatic WHO reporting, and algorithmic signal detection.

The Power BI dashboard represents the command interface of a national respiratory surveillance grid.

This is the infrastructure required for automated “health security” triggers, border protocols, and potential digital health certifications.

PRET: WHO’s Framework for Perpetual Surveillance, Now Active in Egypt

The WHO directly names PRET, acknowledging that Egypt is now being operationally aligned with WHO’s new global framework that replaces traditional outbreak response with permanent readiness.

“The sessions also covered WHO’s Preparedness and Resilience for Emerging Threats (PRET) framework, an innovative approach designed to improve countries’ pandemic preparedness, emphasizing its alignment with Egypt’s national health security priorities.”

PRET is the system designed to bypass the need for treaty ratification by embedding WHO frameworks in national systems through “technical assistance.”

Once PRET is integrated, WHO gains operational influence during any declared emergency.

Naming PRET outright signals that Egypt’s infrastructure is now being shaped to meet PRET’s requirements for sustained respiratory surveillance and rapid WHO-driven response.

Bottom Line

Egypt’s new WHO-guided influenza and respiratory surveillance upgrade is a quiet rollout of PRET—a framework that centralizes global respiratory monitoring under WHO standards and feeds constant influenza, COVID, bird flu, MERS, and zoonotic signals into real-time digital dashboards.

This turns “preparedness” into a perpetual surveillance regime, where respiratory data becomes the trigger for future restrictions, emergency declarations, and global coordination.

What makes the timing more concerning is that these surveillance expansions are happening as multiple governments continue engineering avian influenza viruses with pandemic traits—yet none of these programs are being halted.

PRET ensures the monitoring grid is in place before the next laboratory-engineered pathogen emerges.

With 270 surveillance officials trained across 30 sentinel sites, Egypt’s national system is now synced to WHO’s operational architecture.

And this same PRET-aligned model is being replicated country by country, building a global respiratory surveillance system that never powers down.

WHO, CDC, Gates, and Oxford Were Used to Test Public ‘Compliance’ Strategies for ‘Lower-Quality Vaccines’ Before Any COVID-19 Jabs Existed: ‘PLOS Glob Public Health’ Journal


Raising manipulation concerns.

A newly published PLOS Global Public Health paper confirms that researchers were already running multinational experiments to measure how quickly populations could be moved toward COVID-19 vaccination before any product had been authorized.

The authors state clearly:

“We recruited the respondents in late November 2020… before any [vaccines] were officially approved by a government.”

This places the experiment at a time when the public had no approved vaccine, no final safety data, and no access to Phase 3 trial results.

Yet the study was already testing which institutions—WHO, CDC, Oxford, or the Gates Foundation—were most effective at accelerating public willingness to accept a future vaccine.


The Experiment Focused on Uptake Speed, Not Evidence

The survey’s main outcome variable was not clinical.

It was the speed of compliance:

“Respondents were given five options to express whether and when they would choose to get vaccinated if a vaccine were available at no cost. These options were: ‘Yes, within a month,’ ‘Yes, within 2-3 months,’ ‘Yes, within 4-12 months,’ ‘Yes, after a year,’ and ‘No, never.’”

Those responses were then collapsed into:

  • “early” (within 3 months)
  • “middle” (4–12 months)
  • “late,” which includes “never”

The paper describes vaccine hesitancy entirely in terms of “delay”:

“WHO endorsements, alongside the three other public health organizations examined in this study, are associated with a statistically significant, cross-national reduction in vaccine hesitancy, measured as the delay between vaccine availability and willingness to receive it. Our timing-based measure is a meaningful, yet under-studied, dimension of vaccine uptake that directly speaks to the urgency of public health communication during a pandemic.”

The study did not attempt to measure why individuals might wait for more data or how safety information influences decisions.

Hesitancy was defined only as slowness to accept.

Endorsements Were Randomized to Test Which Authority Moves People Faster

The authors explain that each participant was shown randomized vaccine profiles with or without endorsements from major institutions:

“Our experiment randomly varied exposure to vaccine endorsement information from several prominent global health governance players, including the WHO, the Centers for Disease Control and Prevention (CDC), Oxford University, and the Gates Foundation.”

The goal was to quantify the effect of each authority on changing timing behavior:

“WHO endorsements increase individuals’ willingness to get vaccinated more quickly.”

This design treats institutional influence itself as the variable of interest, not the vaccine.

“[T]rust in scientific authorities, including the WHO, positively correlates with increased public willingness to engage in recommended health practices, such as COVID-19 vaccination and compliance with preventive measures.”

The Paper Acknowledges the Experiment Took Advantage of High Uncertainty

The authors state that their framework relies on the public’s vulnerability during uncertain periods:

“During a novel pandemic, significant uncertainty drives individuals to seek expert guidance on preventive measures such as vaccination.”

The experiment uses that uncertainty to measure which voice is most persuasive.

WHO Was Most Effective When It Spoke Early, Before Other Actors

One of the clearest findings is that WHO’s influence is strongest when it is the first or among the first endorsers:

“The WHO has the greatest impact when it is the first (or among the first) of many organizations to endorse a vaccine.”

And that power drops once other organizations join in:

“[T]he impact of WHO endorsements decreases as additional endorsements from other reputable global health actors emerge.”

The authors explicitly describe this as substitutability, meaning WHO’s influence is higher only when information from other actors is absent.

The Study Also Examined How Endorsements Help Drive Uptake of ‘Low-Quality’ Vaccines

A section of the paper focuses on vaccines with:

  • 50% efficacy,
  • 1-year protection duration,
  • 1 in 10,000 severe side-effect rate,
  • 1 in 30 mild-side-effect rate,

which the authors classify as low-quality vaccines.

The paper states:

“[I]t is crucial to examine the influence of WHO endorsements specifically for lower-quality vaccines, as vaccination intentions for these vaccines are likely to be more sensitive to credible endorsements.”

Their simulation results showed:

“[F]or low-quality vaccines… When people are receptive to WHO endorsements, we observe a distinctly higher vaccination rate over time.”

This shows the study’s purpose was not limited to hypothetical best-case vaccines.

The authors tested how institutional messaging can increase uptake even when vaccine performance is weak.

The Authors Describe Their Work as Global-Level Persuasion Research

Throughout the paper, the focus is on influence, not clinical evaluation:

“This study investigates the influence of World Health Organization (WHO)’s endorsements…”

Endorsements “can accelerate vaccination intentions” and “significantly reduce vaccine hesitancy.”

And the authors frame the absence of evidence as an opportunity:

“During a novel pandemic, significant uncertainty drives individuals to seek expert guidance on preventive measures such as vaccination.”

Rather than studying data quality or risk–benefit communication, the study treats this moment of uncertainty as the condition under which endorsement effects can be most accurately measured.

Conclusion

The record in PLOS Global Public Health shows that researchers in Canada, Japan, and the United States were already measuring which institutions could most effectively accelerate COVID-19 vaccine uptake—for low-quality vaccines—in November 2020, prior to any approved product.

The experiment centered on how quickly people could be influenced to vaccinate, how endorsement messaging changes compliance timing, and how those effects behave under uncertainty or when evaluating lower-quality vaccines.

Every element of the study was built around institutional persuasion.

Not safety, not efficacy, and not informed consent.

When institutions are tested for their ability to speed compliance before safety data even exists, the line between public health guidance and psychological manipulation becomes impossible to ignore.

Moderna Knew in 2017 That Its mRNA Vaccine Lipid Nanoparticles Enter the Bloodstream and Accumulate in the Liver, Spleen, Kidneys, Heart, and Lungs: ‘Molecular Therapy’ Journal


Two whole years before the COVID-19 pandemic during which billions were injected with LNP-containing vaccines, raising informed consent concerns.

Moderna submitted data in November 2017 proving their mRNA vaccine lipid nanoparticles (LNPs) accumulate in mammalian liver, spleen, plasma (blood), kidneys, heart, and lungs—the same technology Moderna and Pfizer later used in billions of COVID-19 doses.

No one who lined up for those shots was ever told—let alone asked to consent—that the lipid nanoparticles carrying the mRNA would traffic through their blood and into their vital organs.

The LNPs were shown to reach major organs and enter the bloodstream within 1 hour.

The particles persisted in those tissues at least 24–48 hours (the Moderna study didn’t track LNP distribution past 2 days), with accumulation when repeatedly dosed.

In November 2017, two years before the COVID-19 pandemic, Sabnis et al. submitted biodistribution data regarding Moderna’s mRNA-1325 Zika vaccine, received by Molecular Therapy journal.

The authors were Moderna’s own scientists.


Main (1)1.63MB ∙ PDF file
Download

The study confirms Moderna’s LNPs—called MC3 (DLin-MC3-DMA)—ended up in mammalian liver, spleen, blood, kidney, heart, and lung:

“Following dosing with MC3 LNPs, lipid was detected in liver, spleen, plasma, kidney, heart, and lung, with liver and spleen containing the largest concentrations. Accumulation of MC3 was observed after each dose. Liver and spleen had the highest levels of lipid 5, however, significantly lower levels than MC3. Lipid 5 was also detected in plasma, lung, and kidney, but not in heart.”

A January 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists bluntly admits that avoiding “unacceptable toxicity” in mRNA vaccines remains a major challenge, warning that “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs all present toxicity concerns” and that the way these vaccines spread through the body can cause harm due to “cell tropism and tissue distribution… and their possible reactogenicity.”

Nevertheless, back in July of this year, the FDA approved the supplemental Biologics License Application (sBLA) for Spikevax®, Moderna’s LNP-containing COVID-19 vaccine, in children 6 months through 11 years of age.

The current head of the FDA is Dr. Martin A. Makary, who was confirmed as Commissioner of Food and Drugs in March.

And now, with their own 2017 biodistribution data in hand, there is no escaping the obvious: Moderna knew exactly where these nanoparticles were going in the body—and they rolled them out to the world anyway.

With repeat blessings from the FDA.

The Claim ‘Vaccines Do Not Cause Autism’ Is Not an Evidence-Based Claim, CDC Confirms


“Because studies have not ruled out the possibility that infant vaccines cause autism.”

The U.S. Centers for Disease Control and Prevention (CDC) has officially declared that there is no evidence to support the claim that vaccines do not cause autism.

Yesterday, the CDC published these historic words:

The claim “vaccines do not cause autism” is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism.

The claim “vaccines do not cause autism” is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism.

HHS has launched a comprehensive assessment of the causes of autism, including investigations on plausible biologic mechanisms and potential causal links.


In an instance of welcome self-reflection and honesty, the CDC announcement went on to admit that the unscientific claim “has historically been disseminated by the CDC and other federal health agencies within HHS to prevent vaccine hesitancy.”

And in an apparent course correction, CDC announced that “HHS has launched a comprehensive assessment of the causes of autism.”

This will include “investigations on plausible biologic mechanisms and potential causal links.”

CDC went on to explain how the rise in autism correlates with the rise in the number of childhood vaccinations:

It is critical to address questions the American people have about the cause of autism to ensure public health guidance is adequately responsive to their concerns. Approximately one in two surveyed parents of autistic children believe vaccines played a role in their child’s autism, often pointing to the vaccines their child received in the first six months of life (Diphtheria, tetanus, pertussis (DTaP), Hepatitis B (HepB), Haemophilus influenzae type B (Hib), Poliovirus, inactivated (IPV), and Pneumococcal conjugate (PCV)) and one given at or after the first year of life (Measles, mumps, rubella (MMR)). This connection has not been properly and thoroughly studied by the scientific community.

In 1986, the CDC’s childhood immunization schedule for infants (≤ 1 year of age) recommended five total doses of vaccines: two oral doses of oral polio vaccine (OPV) and three injected doses of Diphtheria and Tetanus Toxoids and Pertussis Vaccine (DTP). In 2025, the CDC schedule recommended three oral doses of Rotavirus (RV) and three injected doses each of HepB, DTaP, Hib, PCV, and IPV by six months of age, two injected doses of Influenza (IIV) by 7 months of age, and injected doses of Hib, PCV, MMR, Varicella (VAR), and Hepatitis A (HepA) at 12 months of age.

The rise in autism prevalence since the 1980s correlates with the rise in the number of vaccines given to infants. Though the cause of autism is likely to be multi-factorial, the scientific foundation to rule out one potential contributor entirely has not been established. For example, one study found that aluminum adjuvants in vaccines had the highest statistical correlation with the rise in autism prevalence among numerous suspected environmental causes. Correlation does not prove causation, but it does merit further study.

HHS is now researching plausible biological mechanisms between vaccines and autism.

HHS will evaluate plausible biologic mechanisms between early childhood vaccinations and autism. Mechanisms for further investigation include the impacts of aluminum adjuvants, risks for certain children with mitochondrial disorders, harms of neuroinflammation, and more.

CDC provided a chart showing that across three decades of U.S. government reviews, federal agencies (IOM and AHRQ/HHS) have repeatedly concluded that the evidence is insufficient to confirm or rule out a causal link between DTaP/DTP/Tdap/Td vaccines and autism.

The CDC’s newfound scientific approach to autism’s link to vaccines comes after a large McCullough Foundation meta-analysis of 136 studies concluded that childhood vaccination—especially cumulative, clustered, and early-timed dosing—is the strongest modifiable risk factor for autism and other neurodevelopmental disorders.

After decades of denial, the CDC under the Trump administration and HHS Secretary Robert F. Kennedy Jr. has finally taken the first responsible step toward scientific honesty by admitting that vaccines have never been definitively ruled out as a cause of autism.

This is perhaps the strongest decision the agency has made in years.

By abandoning the unscientific slogan and acknowledging the unanswered questions, the CDC has opened the door to the kind of rigorous investigation that should have been undertaken long ago.

For the first time, federal health authorities are conceding that parents’ concerns are legitimate, that autism’s rise demands real answers, and that the expanding vaccine schedule must be scrutinized—not protected.

If the agency continues down this path, the CDC may finally reclaim what it has lacked for a generation: credibility.

We look forward to the CDC being equally honest about COVID-19 vaccines.

DARPA’s Secret 60-Day Pandemic Pipeline: FOIA Documents Reveal U.S. Military Program to Synthesize Viruses From Digital Sequences and Mass-Produce mRNA Countermeasures


Newly released DARPA files show a Pentagon-backed system designed to turn raw genetic code into real viruses, isolate antibodies, and manufacture 20,000 doses of mRNA vaccines in just two months.

This report examines an October 2025 FOIA release from U.S. Right to Know regarding DARPA’s “Pandemic Prevention Platform (P3)” Research Description Document (RDD) from Duke University, Revision 3 (January 2020)—a program that was already operational before the COVID-19 pandemic began.

DARPA’s own words paint the clearest picture yet of a fully integrated pre-COVID pandemic U.S. military system that can:

  • take only a digital sequence of a virus
  • synthesize an infectious clone
  • grow it in a “Thaw-and-Infect” panel of human and animal cell lines
  • isolate antibodies from infected blood
  • evolve those antibodies using computational mutation engines
  • encode those antibodies into modified mRNA
  • package them in lipid nanoparticles
  • and produce 20,000 doses within 60 days

The program is open about building a platform that works even when no physical virus exists, only a computer file.


This newly released document directly reinforces my own research findings—showing that the Wuhan-Hu-1 spike (COVID-19 spike protein), assembled entirely in silico and containing a non-coronavirus-derived mosaic, fits precisely within the digital-first, synthetic-construction pandemic pipeline DARPA had already built before COVID-19 emerged.

And it was precisely this computationally stitched sequence—first published by Wu et al. in Nature (February 2020) without any purified viral isolate or plaque-verified spike protein—that became the official worldwide “reference” antigen used for diagnostics, modeling, mRNA vaccine design, and every subsequent COVID-19 countermeasure.

The DARPA document suggests the disturbing possibility that the COVID-19 “pandemic” may have originated not from a naturally circulating virus, but from a computationally generated sequence that was subsequently treated as a real pathogen and mass-manufactured into international medical countermeasures (“vaccines”).

And because this digitally assembled spike became the sole antigen used by Pfizer and Moderna, the world’s first mass-distributed mRNA vaccines could have effectively programmed billions of human bodies to manufacture the same engineered, domain-modular construct that DARPA’s biodefense pipeline, UPenn’s antibody-engineering platform, and Baric’s NIH-funded chimeric coronavirus system had already optimized long before COVID was declared a pandemic.

In other words, billions of people may have been injected with instructions to manufacture a synthetic, digitally designed spike protein born not from nature, but from a Pentagon–NIH engineering pipeline.

Everything quoted below is verbatim from the FOIA document (HROO11-17-2-0069).

21 F 0004 099.85MB ∙ PDF file
Download

‘Only Electronic Viral Sequence’ May Be Available: DARPA Planned for Digital-Only Outbreaks

DARPA explicitly instructs its contractors to prepare for pandemics where no real virus is ever provided:

“Because we recognize the potential that during a pandemic outbreak only electronic viral sequence information may be available, we will work with Synthetic Genomics Vaccine, Inc. to optimize their protocols for the synthesis of error-free viral infectious clone genome for direct transfection.”

In plain terms, DARPA expected outbreaks where governments supply genome files instead of biological agents, requiring U.S. laboratories to fabricate the infectious agent themselves.

My own 2025 original research papers (The SARS-CoV-2 Reference Spike, and A 32% Human-Derived Mosaic in the In Silico-Assembled SARS-CoV-2 Spike Protein) demonstrate that the Wuhan-Hu-1 (COVID-19 spike protein) spike was built digitally, assembled from bronchoalveolar lavage RNA via un-blinded metagenomic pipelines without human-sequence exclusion.

DARPA’s insistence that full pandemic response must function when “only electronic viral sequence information” exists directly affirms the core premise of Fleetwood’s findings: modern biodefense systems treat digital code as a virus, converting computational constructs into physical biological entities.

The FOIA document reveals that DARPA was funding workflows where a virus is born as data, and only afterward turned into an infectious clone—the same conceptual pathway through which the 32% human-derived mosaic spike emerged.

A Permanent ‘Thaw-and-Infect’ Cell Bank Ready for Unknown Viruses

DARPA required Duke to maintain a frozen library of high-density human, animal, and immortalized cell lines capable of instantly growing nearly any virus—even ones with unknown identity:

“We therefore propose to develop in TAI a ‘Thaw-and-Infect’ eukaryotic cell culture array comprised of cell typesilines competent for the isolation and high titer growth of a variety of known and unknown viral isolates.”

And:

The document proposes to “Identify optimal conditions to generate high density frozen cell stocks (up to 10 cells/mL) that can support virus propagation (up to 500 mL culture volume) 24-48 hours following recovery from cryostasis.”

This is a plug-and-play virus amplification factory—a universal propagation system for both natural and engineered pathogens.

Building Viruses From Scratch With Overlapping Oligos

DARPA contracted Synthetic Genomics (SGI)—now part of Codex DNA—to assemble influenza and other viruses by stitching together DNA fragments:

“Overlapping oligonucleotides… will be pooled, ligated and amplified… error corrected… assembled into linearized plasmid… and delivered… for virus rescue.”

An oligonucleotide is a short, synthetically manufactured piece of DNA or RNA.

This is identical to modern gain-of-function synthetic reconstruction workflows.

My A 32% Human-Derived Mosaic paper argues that the Wuhan-Hu-1 spike mirrors exactly the type of molecule produced by the patented “modular domain substitution” framework in Ralph Baric’s “Methods and compositions for chimeric coronavirus spike proteins” patent US9884895B2.

DARPA’s description of error-corrected assembly via overlapping oligos shows that U.S. programs were routinely generating error-free synthetic viral genomes, matching the precision and modular organization seen in my proposed 32% human-derived mosaic spike.

The Wuhan-Hu-1 spike’s highly ordered placement of human motifs across each pre-engineered domain becomes far more plausible in a system where infectious clones are built, not isolated.

DARPA Planned for ‘Weaponized, Highly Pathogenic’ Influenza Strains

DARPA openly references engineered flu strains as realistic scenarios:

“seasonal or a weaponized, highly pathogenic, influenza strain remains a significant global challenge…”

This appears under “Justification of Pathogens.”

My original research papers show that the spike protein’s functional domains align with synthetic engineering practices developed under NIH-funded coronavirus research.

DARPA’s explicit reference to weaponized strains demonstrates that the U.S. biodefense establishment assumes the existence of engineered pathogens requiring rapid reconstruction and countermeasure systems.

The Wuhan-Hu-1 spike—a modular chimera built from human and coronavirus segments, according to my analyses—aligns squarely with the design space DARPA anticipated.

BioNTech & Acuitas Were Already Embedded Before COVID

DARPA confirms that its mRNA countermeasure (vaccine) system was developed in partnership with BioNTech and Acuitas, the same companies behind the Pfizer COVID-19 vaccine:

“We are advancing our RNA platform for a number of clinical applications including therapeutics and vaccines. Scalable GMP processes have been established for mRNA and lipid nanoparticle production in partnership with BioNTech GmbH and Acuitas Therapeutics.”

This was January 2020.

Before the first public COVID vaccine concepts.

My papers document that the in silico spike—never purified or isolated—became the global mRNA vaccine antigen.

DARPA’s acknowledgment that BioNTech and Acuitas were already integrated into pre-pandemic mRNA production pipelines shows that an infrastructure existed where any uploaded gene sequence could rapidly become an LNP-mRNA product.

This is precisely what happened: the computationally assembled Wuhan-Hu-1 spike instantly became the world’s vaccine antigen because the pandemic-response system was engineered to convert digital sequences into mRNA countermeasures.

DARPA’s Pre-Pandemic Use of Self-Amplifying RNA (SMART RNA Replicons)

DARPA’s program incorporates saRNA replicons:

“In addition to improvements in modified mRNA, we will also evaluate whether RNA replicons can increase peak Ab titer and extend Ab expression in vivo. SGVI has developed a self-amplifying RNA vector based on an alphavirus derived from the attenuated TC-83 strain of Venezuelan equine encephalitis virus that can overcome innate immune response shutdown (vector termed SMART: Synthetically Modified Alpha Replicon Technology). Whole body IVIS imaging of mice injected with either SMART or TC-83 replicon RNA expressing luciferase protein revealed that the SMART RNA expressed significantly more luciferase on days 1, 3 and 7 post-injection and remained higher than the TC-83 replicon until day 14. In addition, luciferase was detected at time points out to 28 days post SMART RNA injection demonstrating significant duration of expression.”

This predates public awareness of saRNA platforms.

DARPA’s 60-Day, 20,000-Dose Manufacturing Pipeline

DARPA describes its end-to-end plan:

“Across the 30-month program we will develop a fully-integrated end-to-end platform that can start with unknown samples from a viral outbreak and be prepared to produce an efficacious and safe CGMP medical countermeasure scalable to 20,000 doses within 60 days.”

The central claim of my original research is that the SARS-CoV-2 spike was produced via an in-silico-to-synthetic-biology pipeline rather than purified from nature.

DARPA’s 60-day manufacturing concept relies on exactly such digital-to-mRNA transformation workflows.

The fact that DARPA required a system capable of producing tens of thousands of doses from only sequence data validates the environment in which the Wuhan-Hu-1 spike emerged: a digital sequence was treated as a ready-made antigen.

Within days of Wu et al. uploading their computer-assembled spike to public databases, Moderna and Pfizer had already converted that digital construct into mRNA vaccine designs—treating an unpurified, in silico sequence as if it were a fully characterized biological antigen.

Bottom Line

This FOIA document exposes a U.S. military program designed to:

  • take a digital file
  • synthesize an infectious clone
  • propagate it in universal cell arrays
  • extract and computationally evolve antibodies
  • encode them in synthetic RNA
  • package them in LNPs
  • and mass-produce mRNA countermeasures in weeks

All before SARS-CoV-2 was publicly known.

When viewed side-by-side with Fleetwood’s research findings, the DARPA P3 document does not merely contextualize the mosaic spike — it confirms its plausibility, providing the operational framework in which a 32% human-derived chimeric spike built from digital assembly becomes not only possible, but expected.

Taken together, the evidence suggests the world may not have experienced a natural viral pandemic, but a global biological rollout built around a digitally assembled spike protein that became the foundation for diagnostics, modeling, and the mass vaccination campaign itself.